These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24406078)

  • 41. MC1R variants increase risk of melanomas harboring BRAF mutations.
    Fargnoli MC; Pike K; Pfeiffer RM; Tsang S; Rozenblum E; Munroe DJ; Golubeva Y; Calista D; Seidenari S; Massi D; Carli P; Bauer J; Elder DE; Bastian BC; Peris K; Landi MT
    J Invest Dermatol; 2008 Oct; 128(10):2485-90. PubMed ID: 18368129
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phenotypic and histologic characteristics of cutaneous melanoma in patients with melanocortin-1 receptor polymorphisms.
    Avilés JA; Lázaro P; Fernández LP; Benítez J; Ibarrola-Villava M; Ribas G
    Actas Dermosifiliogr; 2012 Jan; 103(1):44-50. PubMed ID: 22464597
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Post-translational modification of HINT1 mediates activation of MITF transcriptional activity in human melanoma cells.
    Motzik A; Amir E; Erlich T; Wang J; Kim BG; Han JM; Kim JH; Nechushtan H; Guo M; Razin E; Tshori S
    Oncogene; 2017 Aug; 36(33):4732-4738. PubMed ID: 28394346
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interleukin-like EMT inducer regulates partial phenotype switching in MITF-low melanoma cell lines.
    Noguchi K; Dalton AC; Howley BV; McCall BJ; Yoshida A; Diehl JA; Howe PH
    PLoS One; 2017; 12(5):e0177830. PubMed ID: 28545079
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular characterization of melanoma cases in Denmark suspected of genetic predisposition.
    Wadt KA; Aoude LG; Krogh L; Sunde L; Bojesen A; Grønskov K; Wartacz N; Ek J; Tolstrup-Andersen M; Klarskov-Andersen M; Borg Å; Heegaard S; Kiilgaard JF; Hansen TV; Klein K; Jönsson G; Drzewiecki KT; Dunø M; Hayward NK; Gerdes AM
    PLoS One; 2015; 10(3):e0122662. PubMed ID: 25803691
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MC1R, ASIP, TYR, and TYRP1 gene variants in a population-based series of multiple primary melanomas.
    Helsing P; Nymoen DA; Rootwelt H; Vårdal M; Akslen LA; Molven A; Andresen PA
    Genes Chromosomes Cancer; 2012 Jul; 51(7):654-61. PubMed ID: 22447455
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutated MITF-E87R in Melanoma Enhances Tumor Progression via S100A4.
    Nordlinger A; Dror S; Elkahloun A; Del Rio J; Stubbs E; Golan T; Malcov H; Pricket TD; Cronin JC; Parikh S; Labes S; Thomas L; Yankovitz G; Tabach Y; Levy C; Samuels Y; Khaled M
    J Invest Dermatol; 2018 Oct; 138(10):2216-2223. PubMed ID: 29679610
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Breast cancer suppressor candidate-1 (BCSC-1) is a melanoma tumor suppressor that down regulates MITF.
    Anghel SI; Correa-Rocha R; Budinska E; Boligan KF; Abraham S; Colombetti S; Fontao L; Mariotti A; Rimoldi D; Ghanem GE; Fisher DE; Lévy F; Delorenzi M; Piguet V
    Pigment Cell Melanoma Res; 2012 Jul; 25(4):482-7. PubMed ID: 22594792
    [TBL] [Abstract][Full Text] [Related]  

  • 49. GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells.
    Javelaud D; Alexaki VI; Pierrat MJ; Hoek KS; Dennler S; Van Kempen L; Bertolotto C; Ballotti R; Saule S; Delmas V; Mauviel A
    Pigment Cell Melanoma Res; 2011 Oct; 24(5):932-43. PubMed ID: 21801332
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DNA damage remodels the MITF interactome to increase melanoma genomic instability.
    Binet R; Lambert JP; Tomkova M; Tischfield S; Baggiolini A; Picaud S; Sarkar S; Louphrasitthiphol P; Dias D; Carreira S; Humphrey TC; Fillipakopoulos P; White R; Goding CR
    Genes Dev; 2024 Feb; 38(1-2):70-94. PubMed ID: 38316520
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic and functional evaluation of MITF as a candidate gene for cutaneous melanoma predisposition in pigs.
    Bourneuf E; Du ZQ; Estellé J; Gilbert H; Créchet F; Piton G; Milan D; Geffrotin C; Lathrop M; Demenais F; Rogel-Gaillard C; Vincent-Naulleau S
    Mamm Genome; 2011 Oct; 22(9-10):602-12. PubMed ID: 21626174
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pathways from senescence to melanoma: focus on MITF sumoylation.
    Leclerc J; Ballotti R; Bertolotto C
    Oncogene; 2017 Nov; 36(48):6659-6667. PubMed ID: 28825724
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A conditional zebrafish MITF mutation reveals MITF levels are critical for melanoma promotion vs. regression in vivo.
    Lister JA; Capper A; Zeng Z; Mathers ME; Richardson J; Paranthaman K; Jackson IJ; Elizabeth Patton E
    J Invest Dermatol; 2014 Jan; 134(1):133-140. PubMed ID: 23831555
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Variations of the melanocortin-1 receptor and the glutathione-S transferase T1 and M1 genes in cutaneous malignant melanoma.
    Mössner R; Anders N; König IR; Krüger U; Schmidt D; Berking C; Ziegler A; Brockmöller J; Kaiser R; Volkenandt M; Westphal GA; Reich K
    Arch Dermatol Res; 2007 Jan; 298(8):371-9. PubMed ID: 17072629
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of polymorphic variants in the melanocortin-1 receptor gene with cutaneous pigmentation using an evolutionary approach.
    Kanetsky PA; Ge F; Najarian D; Swoyer J; Panossian S; Schuchter L; Holmes R; Guerry D; Rebbeck TR
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):808-19. PubMed ID: 15159314
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of a melanocyte-specific, microphthalmia-associated transcription factor-dependent regulatory element in the intronic duplication causing hair greying and melanoma in horses.
    Sundström E; Komisarczuk AZ; Jiang L; Golovko A; Navratilova P; Rinkwitz S; Becker TS; Andersson L
    Pigment Cell Melanoma Res; 2012 Jan; 25(1):28-36. PubMed ID: 21883983
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic analysis of melanocortin 1 receptor red hair color variants in a Russian population of Eastern Siberia.
    Motorina AV; Palkina NV; Komina AV; Ruksha TG; Artyukhov IP; Kozlov VV
    Eur J Cancer Prev; 2018 Mar; 27(2):192-196. PubMed ID: 27755135
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MITF: master regulator of melanocyte development and melanoma oncogene.
    Levy C; Khaled M; Fisher DE
    Trends Mol Med; 2006 Sep; 12(9):406-14. PubMed ID: 16899407
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Melanocortin 1 receptor and its influence on naevi and melanoma in dark-skinned phenotypes.
    Smith DJM
    Australas J Dermatol; 2019 Aug; 60(3):192-199. PubMed ID: 30585306
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Estimating the relative risk of developing melanoma in INK4A carriers.
    Berwick M; Orlow I; Mahabir S; Myskowski P; Coit D; Brady MS; Roy P; Song Y; Canchola R; Barz A; Halpern A; Bolognia J; Eng S; Elahi A; Begg CB
    Eur J Cancer Prev; 2004 Feb; 13(1):65-70. PubMed ID: 15075790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.